Chemed Debt to Equity Ratio 2012-2026 | CHE
Current and historical debt to equity ratio values for Chemed (CHE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Chemed debt/equity for the three months ending March 31, 2026 was 0.00.
| Chemed Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-03-31 | $0.69B | $0.85B | 0.81 |
| 2025-12-31 | $0.56B | $0.98B | 0.57 |
| 2025-09-30 | $0.55B | $1.08B | 0.51 |
| 2025-06-30 | $0.52B | $1.20B | 0.43 |
| 2025-03-31 | $0.55B | $1.18B | 0.46 |
| 2024-12-31 | $0.55B | $1.12B | 0.49 |
| 2024-09-30 | $0.53B | $1.24B | 0.43 |
| 2024-06-30 | $0.53B | $1.21B | 0.44 |
| 2024-03-31 | $0.54B | $1.18B | 0.46 |
| 2023-12-31 | $0.56B | $1.11B | 0.51 |
| 2023-09-30 | $0.54B | $1.02B | 0.53 |
| 2023-06-30 | $0.55B | $0.95B | 0.58 |
| 2023-03-31 | $0.55B | $0.88B | 0.63 |
| 2022-12-31 | $0.64B | $0.80B | 0.81 |
| 2022-09-30 | $0.64B | $0.72B | 0.88 |
| 2022-06-30 | $0.63B | $0.69B | 0.92 |
| 2022-03-31 | $0.64B | $0.67B | 0.96 |
| 2021-12-31 | $0.72B | $0.62B | 1.15 |
| 2021-09-30 | $0.54B | $0.78B | 0.69 |
| 2021-06-30 | $0.51B | $0.87B | 0.59 |
| 2021-03-31 | $0.53B | $0.93B | 0.57 |
| 2020-12-31 | $0.53B | $0.90B | 0.59 |
| 2020-09-30 | $0.57B | $0.80B | 0.71 |
| 2020-06-30 | $0.54B | $0.75B | 0.72 |
| 2020-03-31 | $0.59B | $0.68B | 0.87 |
| 2019-12-31 | $0.54B | $0.73B | 0.75 |
| 2019-09-30 | $0.56B | $0.67B | 0.83 |
| 2019-06-30 | $0.48B | $0.62B | 0.77 |
| 2019-03-31 | $0.48B | $0.59B | 0.82 |
| 2018-12-31 | $0.38B | $0.59B | 0.65 |
| 2018-09-30 | $0.41B | $0.57B | 0.72 |
| 2018-06-30 | $0.37B | $0.56B | 0.67 |
| 2018-03-31 | $0.41B | $0.51B | 0.80 |
| 2017-12-31 | $0.38B | $0.54B | 0.70 |
| 2017-09-30 | $0.42B | $0.48B | 0.88 |
| 2017-06-30 | $0.46B | $0.45B | 1.01 |
| 2017-03-31 | $0.39B | $0.50B | 0.77 |
| 2016-12-31 | $0.36B | $0.52B | 0.68 |
| 2016-09-30 | $0.36B | $0.49B | 0.73 |
| 2016-06-30 | $0.39B | $0.46B | 0.85 |
| 2016-03-31 | $0.40B | $0.49B | 0.82 |
| 2015-12-31 | $0.34B | $0.51B | 0.66 |
| 2015-09-30 | $0.41B | $0.49B | 0.84 |
| 2015-06-30 | $0.41B | $0.48B | 0.85 |
| 2015-03-31 | $0.42B | $0.48B | 0.88 |
| 2014-12-31 | $0.41B | $0.45B | 0.91 |
| 2014-09-30 | $0.44B | $0.43B | 1.01 |
| 2014-06-30 | $0.40B | $0.44B | 0.89 |
| 2014-03-31 | $0.42B | $0.45B | 0.95 |
| 2013-12-31 | $0.45B | $0.45B | 0.99 |
| 2013-09-30 | $0.46B | $0.43B | 1.07 |
| 2013-06-30 | $0.42B | $0.48B | 0.87 |
| 2013-03-31 | $0.42B | $0.48B | 0.86 |
| 2012-12-31 | $0.41B | $0.45B | 0.90 |
| 2012-09-30 | $0.39B | $0.48B | 0.82 |
| 2012-06-30 | $0.38B | $0.45B | 0.86 |
| 2012-03-31 | $0.40B | $0.43B | 0.91 |
| 2011-12-31 | $0.38B | $0.41B | 0.92 |
| 2011-09-30 | $0.39B | $0.43B | 0.91 |
| 2011-06-30 | $0.36B | $0.49B | 0.74 |
| 2011-03-31 | $0.36B | $0.46B | 0.77 |
| 2010-12-31 | $0.37B | $0.46B | 0.80 |
| 2010-09-30 | $0.37B | $0.53B | 0.68 |
| 2010-06-30 | $0.35B | $0.51B | 0.69 |
| 2010-03-31 | $0.36B | $0.50B | 0.72 |
| 2009-12-31 | $0.34B | $0.48B | 0.72 |
| 2009-09-30 | $0.34B | $0.46B | 0.75 |
| 2009-06-30 | $0.34B | $0.44B | 0.78 |
| 2009-03-31 | $0.36B | $0.42B | 0.86 |
| 2008-12-31 | $0.36B | $0.40B | 0.91 |
| 2008-09-30 | $0.39B | $0.35B | 1.12 |
| 2008-06-30 | $0.40B | $0.36B | 1.14 |
| 2008-03-31 | $0.40B | $0.37B | 1.10 |
| 2007-12-31 | $0.41B | $0.36B | 1.11 |
| 2007-09-30 | $0.43B | $0.34B | 1.24 |
| 2007-06-30 | $0.46B | $0.33B | 1.40 |
| 2007-03-31 | $0.37B | $0.42B | 0.89 |
| 2006-12-31 | $0.37B | $0.42B | 0.88 |
| 2006-09-30 | $0.37B | $0.42B | 0.88 |
| 2006-06-30 | $0.37B | $0.41B | 0.90 |
| 2006-03-31 | $0.40B | $0.40B | 1.00 |
| 2005-12-31 | $0.46B | $0.38B | 1.18 |
| 2005-09-30 | $0.42B | $0.38B | 1.12 |
| 2005-06-30 | $0.42B | $0.36B | 1.18 |
| 2005-03-31 | $0.44B | $0.35B | 1.28 |
| 2004-12-31 | $0.49B | $0.33B | 1.49 |
| 2004-09-30 | $0.47B | $0.32B | 1.48 |
| 2004-06-30 | $0.47B | $0.31B | 1.55 |
| 2004-03-31 | $0.51B | $0.29B | 1.76 |
| 2003-12-31 | $0.14B | $0.19B | 0.71 |
| 2003-09-30 | $0.13B | $0.20B | 0.65 |
| 2003-06-30 | $0.14B | $0.21B | 0.65 |
| 2003-03-31 | $0.13B | $0.20B | 0.66 |
| 2002-12-31 | $0.13B | $0.21B | 0.59 |
| 2002-09-30 | $0.17B | $0.22B | 0.79 |
| 2002-06-30 | $0.18B | $0.22B | 0.83 |
| 2002-03-31 | $0.19B | $0.21B | 0.90 |
| 2001-12-31 | $0.18B | $0.22B | 0.81 |
| 2001-09-30 | $0.20B | $0.22B | 0.92 |
| 2001-06-30 | $0.20B | $0.22B | 0.93 |
| 2001-03-31 | $0.20B | $0.22B | 0.94 |
| 2000-12-31 | $0.19B | $0.23B | 0.85 |
| 2000-09-30 | $0.22B | $0.21B | 1.03 |
| 2000-06-30 | $0.21B | $0.22B | 0.96 |
| 2000-03-31 | $0.21B | $0.22B | 0.99 |
| 1999-12-31 | $0.21B | $0.21B | 0.99 |
| 1999-09-30 | $0.21B | $0.22B | 0.96 |
| 1999-06-30 | $0.20B | $0.22B | 0.94 |
| 1999-03-31 | $0.21B | $0.22B | 0.95 |
| 1998-12-31 | $0.21B | $0.22B | 0.92 |
| 1998-09-30 | $0.21B | $0.22B | 0.92 |
| 1998-06-30 | $0.21B | $0.22B | 0.97 |
| 1998-03-31 | $0.22B | $0.23B | 0.96 |
| 1997-12-31 | $0.22B | $0.23B | 0.97 |
| 1997-09-30 | $0.27B | $0.23B | 1.18 |
| 1997-06-30 | $0.35B | $0.22B | 1.58 |
| 1997-03-31 | $0.34B | $0.21B | 1.58 |
| 1996-12-31 | $0.34B | $0.22B | 1.57 |
| 1996-09-30 | $0.35B | $0.21B | 1.65 |
| 1996-06-30 | $0.31B | $0.21B | 1.46 |
| 1996-03-31 | $0.32B | $0.21B | 1.49 |
| 1995-12-31 | $0.32B | $0.21B | 1.55 |
| 1995-09-30 | $0.33B | $0.21B | 1.59 |
| 1995-06-30 | $0.32B | $0.19B | 1.64 |
| 1995-03-31 | $0.32B | $0.19B | 1.67 |
| 1994-12-31 | $0.32B | $0.19B | 1.71 |
| 1994-09-30 | $0.30B | $0.15B | 1.95 |
| 1994-06-30 | $0.29B | $0.15B | 1.90 |
| 1994-03-31 | $0.29B | $0.15B | 1.93 |
| 1993-12-31 | $0.29B | $0.14B | 2.14 |
| 1993-09-30 | $0.26B | $0.14B | 1.88 |
| 1993-06-30 | $0.24B | $0.14B | 1.75 |
| 1993-03-31 | $0.24B | $0.14B | 1.79 |
| 1992-12-31 | $0.24B | $0.13B | 1.82 |
| 1992-09-30 | $0.20B | $0.13B | 1.48 |
| 1992-06-30 | $0.20B | $0.14B | 1.46 |
| 1992-03-31 | $0.20B | $0.14B | 1.46 |
| 1991-12-31 | $0.23B | $0.14B | 1.61 |
| 1991-09-30 | $0.22B | $0.14B | 1.58 |
| 1991-06-30 | $0.22B | $0.14B | 1.57 |
| 1991-03-31 | $0.16B | $0.11B | 1.49 |
| 1990-12-31 | $0.22B | $0.11B | 1.91 |
| 1990-09-30 | $0.19B | $0.12B | 1.67 |
| 1990-06-30 | $0.18B | $0.12B | 1.54 |
| 1990-03-31 | $0.17B | $0.13B | 1.30 |
| 1989-12-31 | $0.22B | $0.12B | 1.78 |
| 1989-09-30 | $0.19B | $0.12B | 1.61 |
| 1989-06-30 | $0.19B | $0.12B | 1.57 |
| 1989-03-31 | $0.18B | $0.13B | 1.39 |
| 1988-12-31 | $0.19B | $0.11B | 1.71 |
| 1988-09-30 | $0.21B | $0.12B | 1.79 |
| 1988-06-30 | $0.13B | $0.12B | 1.09 |
| 1988-03-31 | $0.12B | $0.13B | 0.95 |
| 1987-12-31 | $0.13B | $0.11B | 1.17 |
| 1987-09-30 | $0.12B | $0.12B | 0.98 |
| 1987-06-30 | $0.12B | $0.12B | 0.98 |
| 1987-03-31 | $0.12B | $0.12B | 0.98 |
| 1986-12-31 | $0.14B | $0.12B | 1.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |